| RRC ID |
81244
|
| Author |
Suzuki Y, Sato T, Sugimori M, Kanemaru Y, Onodera S, Tsuchiya H, Nakamori Y, Tsuyuki S, Ikeda A, Ikeda R, Goda Y, Kaneko H, Irie K, Sue S, Maeda S.
|
| Title |
Activation of STING in pancreatic cancer-associated fibroblasts exerts an antitumor effect by enhancing tumor immunity.
|
| Journal |
Sci Rep
|
| Abstract |
Pancreatic ductal adenocarcinoma (PDAC) has a high mortality rate; therefore, the development of effective treatments is a priority. The stimulator of interferon genes (STING) pathway enhances tumor immunity by inducing the production of type 1 interferon (IFN) and proinflammatory cytokines and chemokines and promoting the infiltration of cytotoxic T cells. To assess the function of STING on pancreatic tumorigenesis, Ptf1aER-Cre/+ LSL-KrasG12D/+ p53loxP/loxP mice (KPC mice) and Ptf1aER-Cre/+ LSL-KrasG12D/+ p53loxP/loxP/STING-/- mice (KPCS mice) were generated. However, STING deletion did not affect pancreatic tumorigenesis in mice. Because STING is expressed not only in immune cells but also in cancer-associated fibroblasts (CAFs), we evaluated the STING function in PDAC CAFs. A mouse STING agonist 5,6-Dimethyl-9-oxo-9H-xanthene-4-acetic acid (DMXAA) was administered to KPC mice and CAFs from KPC mice and the resulting immune response was evaluated. DMXAA activated STING in PDAC CAFs in KPC mice, promoting cytotoxic T cell infiltration by secreting proinflammatory cytokines and enhancing tumor immunity. We next generated STING-deficient PDAC cells and subcutaneous tumors in which STING was expressed only in CAFs by performing bone marrow transplantation and assessed the antitumor effect of STING-activated CAFs. The administration of DMXAA to subcutaneous tumors expressing STING only in CAFs sustained the antitumor effect of DMXAA. About half of human PDACs lacked STING expression in the cancer stroma, suggesting that STING activation in PDAC CAFs exerts an antitumor effect, and STING agonists can be more effective in tumors with high than in those with low STING expression in the stroma.
|
| Volume |
14(1)
|
| Pages |
17071
|
| Published |
2024-7-24
|
| DOI |
10.1038/s41598-024-68061-y
|
| PII |
10.1038/s41598-024-68061-y
|
| PMID |
39048609
|
| PMC |
PMC11269671
|
| MeSH |
Animals
Cancer-Associated Fibroblasts* / metabolism
Carcinoma, Pancreatic Ductal* / drug therapy
Carcinoma, Pancreatic Ductal* / genetics
Carcinoma, Pancreatic Ductal* / immunology
Carcinoma, Pancreatic Ductal* / metabolism
Carcinoma, Pancreatic Ductal* / pathology
Cell Line, Tumor
Humans
Membrane Proteins* / genetics
Membrane Proteins* / metabolism
Mice
Pancreatic Neoplasms* / immunology
Pancreatic Neoplasms* / metabolism
Pancreatic Neoplasms* / pathology
T-Lymphocytes, Cytotoxic / immunology
Xanthones / pharmacology
|
| IF |
3.998
|
| Resource |
| Mice |
RBRC09881 |
